ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004

NCI director apologizes to cancer centers for inaction on working group report.

October 31, 2003

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods

August 12, 1977

Also in this 8-page issue: NCI contract will keep Cancer Genetics Network database alive, but center grants will not be recompeted.

July 23, 2004

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007